Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle
2020 · npj Vaccines · 29 citations
https://doi.org/10.1038/s41541-020-00212-4
N
Nadia Oreshkova
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
2.3K
Citations
15
h-index
18
i10-index
Nadia Oreshkova is an academic researcher from Wageningen University & Research. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral Infections and Vectors & Viral Infections and Outbreaks Research. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0000-0001-8830-7055Papers by this author
worksEngineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase
2023 · Nature Communications · 13 citations
https://doi.org/10.1038/s41467-023-36754-z
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters
2022 · Vaccine · 6 citations
https://doi.org/10.1016/j.vaccine.2022.07.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat